Share Your Comments and Experiences in Support of Extending HPV Vaccine Coverage to U.S. Boys and Young Men
September 15, 2009
The number of people who are able to receive the HPV (Human Papillomavirus) vaccine Gardasil may be about to double. But will the number of people who can afford to get it follow suit?
Gardasil was approved by the U.S. Food and Drug Administration (FDA) in 2006, and as of September 2009 it was indicated for girls and women between the ages of 9 and 26. It protects people from becoming infected with four types of human papillomavirus (HPV), two of which are responsible for about 70 percent of cervical cancers worldwide.
But, according to recent research, Gardasil seems to be effective in males as well; it appears to help prevent genital warts, as well as anal cancer, penile cancer and other types of cancers that are potentially caused by HPV.View Full Article
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)